Sanofi’s type 1 diabetes drug recommended for EU approval
Nov 14 (Reuters) – The European Medicines Agency’s committee has recommended approval of French drugmaker Sanofi’s (SASY.PA)opens new tab first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of…